Cancer Treatment and Research Communications Oncology

PD-L1 alone versus a five-variable genomic-immunotherapy score for predicting response to immune-checkpoint inhibitors in a real-world multi-tumor cohort: a molecular pathology perspective

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →